Intervention Review

St John's wort for major depression

  1. Klaus Linde1,*,
  2. Michael M Berner2,
  3. Levente Kriston2

Editorial Group: Cochrane Depression, Anxiety and Neurosis Group

Published Online: 8 OCT 2008

Assessed as up-to-date: 7 AUG 2008

DOI: 10.1002/14651858.CD000448.pub3

How to Cite

Linde K, Berner MM, Kriston L. St John's wort for major depression. Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD000448. DOI: 10.1002/14651858.CD000448.pub3.

Author Information

  1. 1

    Technische Universität München / Klinikum rechts der Isar, Institut für Allgemeinmedizin / Institute of General Practice, München, Germany

  2. 2

    University Medical Center Freiburg, Department of Psychiatry and Psychotherapy, Freiburg im Breisgau, Germany

*Klaus Linde, Institut für Allgemeinmedizin / Institute of General Practice, Technische Universität München / Klinikum rechts der Isar, Wolfgangstr. 8, München, 81667, Germany. Klaus.Linde@lrz.tu-muenchen.de.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 OCT 2008

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Daniel Jakobs, Anne Hage-Hülsmann, Lars Prenner, Christiane Kolb, Dieter Weiser, Hanns Häberlein, Downregulation of β1-adrenergic receptors in rat C6 glioblastoma cells by hyperforin and hyperoside from St John's wort, Journal of Pharmacy and Pharmacology, 2013, 65, 6
  2. 2
    Daniela Solomon, Jon Adams, Nicholas Graves, Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression, Journal of Affective Disorders, 2013, 148, 2-3, 228

    CrossRef

  3. 3
    Charles W. Popper, Mood Disorders in Youth, Child and Adolescent Psychiatric Clinics of North America, 2013, 22, 3, 403

    CrossRef

  4. 4
    Jerome Sarris, St. John's Wort for the Treatment of Psychiatric Disorders, Psychiatric Clinics of North America, 2013, 36, 1, 65

    CrossRef

  5. 5
    Tazimuddin Kazi, Nazreen Hussain, Paul Bremner, Adrian Slater, Caroline Howard, The application of a DNA-based identification technique to over-the-counter herbal medicines, Fitoterapia, 2013, 87, 27

    CrossRef

  6. 6
    Masoud Nikfarjam, Neda Parvin, Naziheh Assarzadegan, Shabnam Asghari, The Effects of Lavandula Angustifolia Mill Infusion on Depression in Patients Using Citalopram: A comparison Study, Iranian Red Crescent Medical Journal, 2013, 15, 8, 734

    CrossRef

  7. 7
    Harald Walach, Placebo and Pain, 2013,

    CrossRef

  8. 8
    Tom M McLellan, Harris R Lieberman, Do energy drinks contain active components other than caffeine?, Nutrition Reviews, 2012, 70, 12
  9. 9
    Peter Kooreman, Erik W. Baars, Patients whose GP knows complementary medicine tend to have lower costs and live longer, The European Journal of Health Economics, 2012, 13, 6, 769

    CrossRef

  10. 10
    Caroline Howard, Eleni Socratous, Sarah Williams, Eleanor Graham, Mark R Fowler, Nigel W Scott, Paul D Bremner, Adrian Slater, PlantID – DNA-based identification of multiple medicinal plants in complex mixtures, Chinese Medicine, 2012, 7, 1, 18

    CrossRef

  11. 11
    Joshua Tessier, Richard Glickman-Simon, Touch Therapy, Tripterygium Hypoglaucum Hutch, Cortical Electrostimulation, Sericite Belt, and Hypericum Extract, EXPLORE: The Journal of Science and Healing, 2012, 8, 6, 373

    CrossRef

  12. 12
    Paul Rutter, David Newby, Community Pharmacy Australia and New Zealand edition, 2012,

    CrossRef

  13. 13
    Heide Hecht, Michael M. Berner, Alric Rüther, Gerd Antes, Mathias Berger, Psychische Erkrankungen, 2012,

    CrossRef

  14. 14
    Joyce K. Anastasi, Michelle Chang, Bernadette Capili, Herbal Supplements: Talking with your Patients, The Journal for Nurse Practitioners, 2011, 7, 1, 29

    CrossRef

  15. 15
    Stania A. Dejesus, Vanessa A. Diaz, Wanda C. Gonsalves, Peter J. Carek, Identification and Treatment of Depression in Minority Populations, The International Journal of Psychiatry in Medicine, 2011, 42, 1, 69

    CrossRef

  16. 16
    Vijeta Thakor, Matthew J. Leach, David Gillham, Adrian Esterman, The quality of information on websites selling St. John's wort, Complementary Therapies in Medicine, 2011, 19, 3, 155

    CrossRef

  17. 17
    Mark Hyman Rapaport, Andrew A. Nierenberg, Robert Howland, Christina Dording, Pamela J. Schettler, David Mischoulon, The treatment of minor depression with St. John’s Wort or citalopram: Failure to show benefit over placebo, Journal of Psychiatric Research, 2011, 45, 7, 931

    CrossRef

  18. 18
    Donald N. Tsynman, Savanna Thor, Joyann A. Kroser, Treatment of Irritable Bowel Syndrome in Women, Gastroenterology Clinics of North America, 2011, 40, 2, 265

    CrossRef

  19. 19
    A Guide to Evidence-based Integrative and Complementary Medicine, 2011,

    CrossRef

  20. 20
    A Guide to Evidence-based Integrative and Complementary Medicine, 2011,

    CrossRef

  21. 21
    A Guide to Evidence-based Integrative and Complementary Medicine, 2011,

    CrossRef

  22. 22
    Sara A. Fleming, Nancy C. Gutknecht, Naturopathy and the Primary Care Practice, Primary Care: Clinics in Office Practice, 2010, 37, 1, 119

    CrossRef

  23. 23
    Raffaella Filippini, Anna Piovan, Anna Borsarini, Rosy Caniato, Study of dynamic accumulation of secondary metabolites in three subspecies of Hypericum perforatum, Fitoterapia, 2010, 81, 2, 115

    CrossRef

  24. 24
    Frank Miller, Tim Friede, Meinhard Kieser, Blinded assessment of treatment effects utilizing information about the randomization block length, Statistics in Medicine, 2009, 28, 12
  25. 25
    David Peters, CAM: doing more good than harm, Focus on Alternative and Complementary Therapies, 2009, 14, 3
  26. 26
    Andrea Cipriani, Marianna Purgato, Toshi A Furukawa, Carlotta Trespidi, Giuseppe Imperadore, Alessandra Signoretti, Rachel Churchill, Norio Watanabe, Corrado Barbui, Citalopram versus other anti-depressive agents for depression, The Cochrane Library,
  27. 27
    Andrea Cipriani, Markus Koesters, Toshi A Furukawa, Michela Nosè, Marianna Purgato, Ichiro M Omori, Carlotta Trespidi, Corrado Barbui, Duloxetine versus other anti-depressive agents for depression, The Cochrane Library,
  28. 28
    Andrea Cipriani, Claudio Santilli, Toshi A Furukawa, Alessandra Signoretti, Atsuo Nakagawa, Hugh McGuire, Rachel Churchill, Corrado Barbui, Escitalopram versus other antidepressive agents for depression, The Cochrane Library,
  29. 29
    Ichiro M Omori, Norio Watanabe, Atsuo Nakagawa, Andrea Cipriani, Corrado Barbui, Hugh McGuire, Rachel Churchill, Toshi A Furukawa, Fluvoxamine versus other anti-depressive agents for depression, The Cochrane Library,
  30. 30
    Martin S. Lennard, Herb–Drug and Food–Drug Interactions, Encyclopedia of Drug Metabolism and Interactions,
  31. 31
    Low-Carbon Clinical Care,
  32. 32
    Atsuo Nakagawa, Norio Watanabe, Ichiro M Omori, Corrado Barbui, Andrea Cipriani, Hugh McGuire, Rachel Churchill, Toshi A Furukawa, Milnacipran versus other antidepressive agents for depression, The Cochrane Library,
  33. 33
    Bill Gurley, Kim E. Fifer, Zöe Gardner, Phytochemical Modulators of Human Drug Metabolism: Drug Interactions with Fruits, Vegetables, and Botanical Dietary Supplements, Encyclopedia of Drug Metabolism and Interactions,
  34. 34
    References,
  35. 35
    Andrea Cipriani, Teresa La Ferla, Toshi A Furukawa, Alessandra Signoretti, Atsuo Nakagawa, Rachel Churchill, Hugh McGuire, Corrado Barbui, Sertraline versus other antidepressive agents for depression, The Cochrane Library,
  36. 36
    Andrea Cipriani, Teresa La Ferla, Toshi A Furukawa, Alessandra Signoretti, Atsuo Nakagawa, Rachel Churchill, Hugh McGuire, Corrado Barbui, Sertraline versus other antidepressive agents for depression, The Cochrane Library,
  37. 37
    Andrea Cipriani, Teresa La Ferla, Toshi A Furukawa, Alessandra Signoretti, Atsuo Nakagawa, Rachel Churchill, Hugh McGuire, Corrado Barbui, Sertraline versus other antidepressive agents for depression, The Cochrane Library,